Clinical Trials Browser

Phase 3 × GV1001 peptide × Gastrointestinal × Clear all

NCT02854072 2016-11-22

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00358566 2008-05-19

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Phase 3 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms